# THCV

Type: Technology

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/thcv
Canonical HTML page: https://getbiobrief.com/entity/thcv

## Recent coverage (1 stories)

### Cannabis Compounds Show Potential to Reverse MASLD in One-Third of Adults
2026-03-10 03:37:36 · Sentiment: Positive · Impact: 6/10 · Sources: 2

Emerging research indicates that specific non-psychoactive cannabis compounds, particularly THCV, may reverse Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). This breakthrough offers a potential pharmaceutical path for a condition that currently affects nearly 33% of the global adult population.
Full story: https://getbiobrief.com/story/cannabis-compounds-reverse-liver-disease-masld

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.